Meilleure Health International Industry Group (HKSE:02327) YoY EBITDA Growth : 125.00% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Meilleure Health International Industry Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Meilleure Health International Industry Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 125.00%.

Meilleure Health International Industry Group's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.01.

Meilleure Health International Industry Group YoY EBITDA Growth Historical Data

The historical data trend for Meilleure Health International Industry Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meilleure Health International Industry Group YoY EBITDA Growth Chart

Meilleure Health International Industry Group Annual Data

Trend

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-87.50

625.00

-20.69

-56.52

60.00

Meilleure Health International Industry Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-41.67	-66.67	-42.86	40.00	125.00

Meilleure Health International Industry Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Meilleure Health International Industry Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.016	-	0.01)	/	\| 0.01 \|
=	60.00 %

Meilleure Health International Industry Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.009	-	0.004)	/	\| 0.004 \|
=	125.00 %

Meilleure Health International Industry Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Meilleure Health International Industry Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Meilleure Health International Industry Group (HKSE:02327) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Meilleure Health International Industry Group Ltd (HKSE:02327) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

89 Queensway, Unit 2906, Tower 1, Lippo Centre, Admiralty, Hong Kong, HKG

Website

http://www.meilleure.com.cn

Meilleure Health International Industry Group Ltd is an investment holding company principally engaged in the trading of healthcare products, chemical materials, and building materials. The company's operating segment includes Trading business; Agency service; Property development; Property investment and leasing; Healthcare related business and Industrial hemp business. The Trading business segment includes the trading of construction materials. Geographically, it derives a majority of revenue from PRC.

Meilleure Health International Industry Group (HKSE:02327) Headlines

No Headlines